FOR IMMEDIATE RELEASE
MESA, Ariz. — August 13, 2022
We are delighted to announce that two of our research papers, “Meta-Analysis of Veress Needle Entry Versus Direct Trocar Entry in Gynecologic Surgery” and “Meta-Analysis Of Laparoscopic Radical Hysterectomy Vs. Robotic Assisted Radical Hysterectomy For Early Stage Cervical Cancer” have been accepted for oral presentation at the AAGL Global Congress in Aurora, Colorado in December 2022. Most of our research staff plans on attending, and we hope to see many of our old and new friends at the conference!
About the Marchand Institute for Minimally Invasive Surgery
The Marchand Institute for Minimally Invasive Surgery is a 501(c)(3) tax-exempt non-profit research and educational institution based in Mesa, Arizona (EIN 42-2857240). The Institute produces peer-reviewed systematic reviews and meta-analyses in minimally invasive gynecologic surgery and women’s health, conducts FDA clinical trials, and trains surgeons through an SLS-accredited fellowship. All reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised using the Cochrane RoB 2 tool. The Institute accepts no pharmaceutical or medical device industry funding and declares no conflicts of interest. It is directed by Greg J. Marchand, MD, FACS, FACOG, FICS.
Media Contact
Maria A. Sainz, Director of Communications and Media Relations
Marchand Institute for Minimally Invasive Surgery
maria@marchandobgyn.com | (480) 999-0905
Interview requests, expert commentary topics, boilerplate and high-resolution images: Newsroom & Press Kit. Complete publication record with DOIs and PMIDs: Publications database. Methodology: How we run a review.
###